Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
Nishimura A, Aoki Y, Ishiwata Y, Ichimura T, Ueyama J, Kawahara Y, Tomoda T, Inoue M, Matsumoto K, Inoue K, Hiroki H, Ono S, Yamashita M, Okano T, Tanaka-Kubota M, Ashiarai M, Miyamoto S, Miyawaki R, Yamagishi C, Tezuka M, Okawa T, Hoshino A, Endo A, Yasuhara M, Kamiya T, Mitsuiki N, Ono T, Isoda T, Yanagimachi M, Tomizawa D, Nagasawa M, Mizutani S, Kajiwara M, Takagi M, Kanegane H, Imai K, Morio T. Nishimura A, et al. Among authors: aoki y. J Clin Immunol. 2021 Jul;41(5):944-957. doi: 10.1007/s10875-021-00966-z. Epub 2021 Feb 1. J Clin Immunol. 2021. PMID: 33527309
HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.
Takagi M, Ishiwata Y, Aoki Y, Miyamoto S, Hoshino A, Matsumoto K, Nishimura A, Tanaka M, Yanagimachi M, Mitsuiki N, Imai K, Kanegane H, Kajiwara M, Takikawa K, Mae T, Tomita O, Fujimura J, Yasuhara M, Tomizawa D, Mizutani S, Morio T. Takagi M, et al. Among authors: aoki y. Int J Hematol. 2017 May;105(5):686-691. doi: 10.1007/s12185-017-2187-3. Epub 2017 Feb 9. Int J Hematol. 2017. PMID: 28185203
Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.
Noguchi Y, Tomizawa D, Hiroki H, Miyamoto S, Tezuka M, Miyawaki R, Tanaka-Kubota M, Okano T, Kobayashi C, Mitsuiki N, Aoki Y, Imai K, Kajiwara M, Kanegane H, Morio T, Takagi M. Noguchi Y, et al. Among authors: aoki y. Clin Case Rep. 2018 Apr 10;6(6):1023-1028. doi: 10.1002/ccr3.1506. eCollection 2018 Jun. Clin Case Rep. 2018. PMID: 29881556 Free PMC article.
Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.
Nagasawa M, Ohkawa T, Endo A, Mitsuiki N, Ono T, Aoki Y, Isoda T, Tomizawa D, Takagi M, Kajiwara M, Morio T, Mizutani S. Nagasawa M, et al. Among authors: aoki y. Int J Hematol. 2013 Nov;98(5):533-42. doi: 10.1007/s12185-013-1443-4. Epub 2013 Oct 1. Int J Hematol. 2013. PMID: 24081926
3,558 results